Study for Adolescents and Adults With Ornithine Transcarbamylase Deficiency to Evaluate Safety and Tolerability of ARCT-810
Clinical trial NCT05526066 · TERMINATED
Trial details
- NCT number
- NCT05526066
- Sponsor
- Arcturus Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-17
- Primary completion
- 2024-10-31
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.